Stay updated on Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Sign up to get notified when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added detailed bone mineral density (BMD) Z-score change data at weeks 17, 41, 57, and 105 with race/age/gender standardization. Introduced summaries of participant satisfaction and product preference at Weeks 17 and 41, and removed older dated entries (2025-09 and 2025-10-10).
    Difference
    0.4%
    Check dated 2026-03-26T11:22:14.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:13:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:37:06.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown on the page. The previous funding-status notice and Revision: v3.4.1 have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T12:40:31.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center status; updated page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:55:25.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0. Removed or renamed: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T04:55:23.000Z thumbnail image

Stay in the know with updates to Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.